Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Rho kinases in cardiovascular physiology and pathophysiology Loirand G; Guerin P; Pacaud PCirc Res 2006[Feb]; 98 (3): 322-34Rho kinases (ROCKs) are the first and the best-characterized effectors of the small G-protein RhoA. In addition to their effect on actin organization, or through this effect, ROCKs have been found to regulate a wide range of fundamental cell functions such as contraction, motility, proliferation, and apoptosis. Abnormal activation of the RhoA/ROCK pathway has been observed in major cardiovascular disorders such as atherosclerosis, restenosis, hypertension, pulmonary hypertension, and cardiac hypertrophy. This review, based on recent molecular, cellular, and animal studies, focuses on the current understanding of ROCK signaling and its roles in cardiovascular physiology and pathophysiology.|*Cardiovascular Physiological Phenomena[MESH]|Atherosclerosis/enzymology/physiopathology[MESH]|Cardiovascular Diseases/enzymology/*physiopathology[MESH]|Cardiovascular System/*physiopathology[MESH]|Coronary Restenosis[MESH]|Endothelium, Vascular/physiology[MESH]|Humans[MESH]|Hypertension/enzymology/physiopathology[MESH]|Inflammation/enzymology/physiopathology[MESH]|Intracellular Signaling Peptides and Proteins/*metabolism[MESH]|Muscle, Smooth, Vascular/physiology[MESH]|Protein Serine-Threonine Kinases/*metabolism[MESH]|rho-Associated Kinases[MESH] |
